
Medicare launches GLP-1 Bridge program for weight management
Starting July 1, 2026, eligible Medicare Part D patients will gain access to weight management medications Foundayo and Zepbound for a flat monthly cost of $50, marking a significant shift in federal coverage policy for obesity treatments previously excluded from broad Medicare support.



























